Cloud Pharmaceuticals s is headquartered in Research Triangle Park, North Carolina.
Cloud Pharmaceuticals is committed to improving health and well-being through the computational design and rapid development of new therapies. We use a proprietary design process that combines artificial intelligence (AI) and cloud computing to search virtual molecular space and applies along sophisticated molecular modeling to design novel drugs that are well-qualified for development from the outset and have original composition of matter IP. The process enables faster drug development progress at lower cost and a higher success rate and better targeting of hard-to-drug indications. Our approach amplifies the power of cloud computing and AI to radically improve drug discovery and design. We partner at all stages of drug development – from discovery through the clinic – and are building an extensive product pipeline that spans a wide range of indications.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 29, 2014 | Grant | $174.95K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |